Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.
about
Genetic variation of hepatitis B virus and its significance for pathogenesisMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsPredicting resistance mutations using protein design algorithmsrtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virusLong-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.Antiviral treatment of chronic hepatitis B virus (HBV) infectionsComparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroBiological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model.Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.Antiviral resistance and hepatitis B therapy.Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems.Monotherapy versus combination therapy for the treatment of chronic hepatitis B.Experimental models and therapeutic approaches for HBV.Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen.Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.Clonal evolution of hepatitis B virus polymerase gene mutations during lamivudine-adefovir combination treatment.Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B.Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites.Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis
P2860
Q26772348-25E20B66-08F6-449C-993D-F2C013B8384DQ27002598-73250FC9-DBF4-4874-93E7-D6764E82631BQ27663576-0CEBC5FE-B880-41AA-969B-114476181125Q28540082-AD70B77C-210A-4B22-89D7-ED354DE20EBDQ33417353-BF916984-C8CC-4F10-AD8D-784446CA05EFQ34045308-ADB364BF-374F-4104-ADC0-44717AAD5CF7Q34223779-B5345962-A694-4B7C-B8D5-743C00F6B937Q34489239-7BC9240E-93DB-48D8-8F92-658A89B40A33Q35879053-63C649EB-63B0-4A12-A210-B1E23E96D0B2Q36448260-0B605F0A-99C9-4537-AE5D-9C337EFEC8B0Q36516176-95F14FF5-E031-4294-BEC5-B30357112784Q36698116-45F3501D-A5A0-41D5-922F-45DC5859F7A8Q37255008-55B9C04B-65CD-4479-B65F-0880ECDAD113Q37504755-773A5A15-B515-46C7-8CEC-AC5C80C04871Q37620354-172FDA8C-6C0C-47D7-910A-AB8995D66CEBQ38035173-37006ECF-48ED-4F79-8DCD-8DA4F97A95B4Q39593181-2E84E6E0-B13F-4910-9B02-F6CCC640DFBAQ39988589-AEEB1C27-264C-41D4-A680-479492CE2F0AQ40260177-CDF52708-376F-4780-836B-3BD45FC4D131Q42131024-05721E59-F8A4-488F-9F76-D2275CEC2359Q42910007-832FD69C-8E11-4684-A57A-61D7F9A4788FQ44418225-A1F70449-AB60-4C04-98F5-1C7570829C44Q45363333-55C3C905-2FAA-4789-8B6F-98F1C10544B1Q45388069-4B3C400D-DD91-413E-B2EA-17BB2F84A1C7Q58727285-B3A522FC-F968-4BC6-8278-0544AE9F8873
P2860
Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@en
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@nl
type
label
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@en
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@nl
prefLabel
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@en
Emergence of a novel lamivudin ...... tution outside the YMDD motif.
@nl
P2093
P2860
P356
P1476
Emergence of a novel lamivudin ...... itution outside the YMDD motif
@en
P2093
Chiemi Noguchi
Chise Tateno
Fumitaka Suzuki
Hidenori Ochi
Hiromi Abe
Hiromi Yatsuji
Hiromitsu Kumada
Katsutoshi Yoshizato
Kazuaki Chayama
P2860
P304
P356
10.1128/AAC.00239-06
P407
P577
2006-09-18T00:00:00Z